INTRODuCTION
Reperfusion therapy with primary PCI is the recommended treatment for all patients with ST segment elevation acute myocardial infarction (STEMI) presenting within twelve hours from the onset of symptoms. 1 Early reperfusion of the infarct-related coronary artery (IRA) has a significant impact on patient outcomes after a STEMI episode. 2 Several studies have confirmed a strong association between myocardial ischemic time on one hand, and infarct size and mortality, on the other hand.
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Reperfusion of the infarct-related artery can be achieved preferably by primary percutaneous coronary intervention (pPCI) or, when this is not available, within the recommended timeframe for logistic reasons, by fibrinolysis. In both cases, the time from coronary occlusion to reperfusion is crucial for the patient's progress.
The European Myocardial Infarction Project Group
found that the administration of fibrinolytic therapy in STEMI , one hour earlier, saved fifteen more lives days per 1,000 patients treated, at thirty days. 3 Boersmaet et al. analysed over 50,000 STEMI patients from twenty-two randomized trials, and showed that the administration of a thrombolytic agent in patients presenting within one hour of the onset of symptoms saved sixty-five more lives per 1,000 patients, compared with patients whose treatment was commenced at a longer period from the onset of symptoms. 4 The best clinical results of reperfusion by pPCI have been observed in patients treated up to 120 minutes from the onset of symptoms. [5] [6] [7] [8] [9] [10] In 1,400 patients with acute myocardial infarction treated with primary angioplasty, followed-up for thirteen years, Brodie et al. found that thirty-day mortality was lowest with early reperfusion (4.3% when reperfusion has been achieved <two hours vs.
9.2% when reperfusion has been achieved after more than two hours), and was relatively independent of time to reperfusion after two hours (9.0% for reperfusion at two to four hours, 9.3% for reperfusion at four to six hours, and 9.5% for reperfusion at more than six hours). The present study aimed to investigate the differences in critical network times and the association with in-hospital mortality of STEMI patients presenting at regional hospitals belonging to the same STEMI network, but located at different distances from the pPCI center.
METHODS
We carried out an analysis of recorded critical network minutes for nearby territorial hospitals to a maximum of 150 minutes for more distant regional hospitals.
The algorithm was different for patients presenting directly at the pPCI center. These patients were first examined in the emergency unit, and whenever an acute coronary syndrome was suspected, a cardiologist was called to confirm the diagnosis. As soon as the STEMI diagnosis was confirmed, the cardiac catheterization laboratory was prepared, the patient was transferred there, and interventional treatment was initiated.
The 416 STEMI patients included in the present study were divided into four groups according to the distance from the regional hospital to the pPCI center. • presentation time (PT);
• protocol initiation time (PIT);
• door-to-balloon time (DTB);
• ischemic time (IT).
Definitions
Presentation time was defined as the time from the onset of symptoms to the first medical contact. The first medical contact (FMC) was defined as the point at which the patient was either initially assessed by medical personnel in the pre-hospital setting, or the patient arrived at the hospital emergency department.
Protocol initiation time was defined as the time from the first medical contact to the initiation of the STEMI protocol.
The door-to-balloon time (DTB) was defined as the time between arrival at the pPCI center and balloon inflation.
Ischemic time (IT) was defined as the time from the onset of symptoms to revascularization.
The study endpoint was the in-hospital mortality of the patients presenting directly to the primary PCI center or referred from the territorial hospitals located at different distances from the pPCI center.
The study protocol was approved by the ethics committee of the institution where the study was conducted, and all patients gave their informed consent for participation in the study. The study was carried out in accordance with the principles stipulated in the Declaration of Helsinki. 
RESuLTS

Presentation time
Presentation time (PT) showed no significant difference between the four groups. This time was higher among patients presenting to the territorial hospital from Zone 2 and Zone 1, compared with patients referred from the territorial hospital located in Zone 3 or those admitted directly to the pPCI center. These differences were not sta- 
Protocol initiation time
Protocol initiation time (PIT) was significantly lower in patients referred from the territorial hospitals located in 
total myocarDial ischemic time
Total ischemic time (IT) was not significantly different 
in-hosPital mortality of stemi Patients
Mortality rates were similar in all the study groups. The lowest mortality was recorded in STEMI patients presenting to the territorial hospitals located in Zone 3. There were no significant differences between the groups regarding inhospital mortality, this being 3.5% in the pPCI center, 3.9%
in Zone 1, 3.7% in Zone 2 and 3.2% in Zone 3 ( Figure 6 ).
DISCuSSIONS
Myocardial ischemic time is a powerful determinant of mortality in STEMI patients. Therefore, reduction of the total ischemic time should be the primary goal of network organization in an STEMI network.
There are several critical time intervals which need to be considered in reducing the total ischemic time of STEMI patients. The first is the time from the infarctrelated artery occlusion to the onset of symptoms. There is a certain period which elapses from the occlusion of the infarct-related coronary artery to the development of symptoms of myocardial infarction. 12 The second is the time from the onset of symptoms to the first medical contact. This depends on the ability of the patient to realize the seriousness of the problem and to communicate with an emergency service. The present results showed long presentation times (>160 minutes) in all four groups, with no significant differences between the groups. In a UK study, the median interval from the onset of symptoms to hospital presentation was 2.2 hours. 13 In the United
States, a survey of 18,928 STEMI patients found that 50% of patients were delayed for more than four hours before they reached a hospital. 14 al ischemic time and one-year mortality in 1,800 STEMI patients treated with pPCI. They found that the relative mortality risk increased by 7.5% for every thirty-minute delay before reperfusion. 18 As a result of the similar total ischemic times, the STEMI patients referred from the territorial hospitals to the pPCI center had similar mortality rates (3.9 vs.
3.7 vs 3.2 vs 3.5), with a slightly lower mortality in cases of the patients presenting directly to the pPCI center. This shows that reducing the system delay by a well-organized STEMI network can provide a similar chance of survival for patients living at a distance from the pPCI center compared
to patients who present directly to the pPCI center.
In a retrospective study, Swaminathan et al. analysed 82,678 STEMI patients who underwent primary PCI and were enrolled in the National Cardiovascular Data Registry, and found that in-hospital mortality for patients with significant network-related delays was significantly higher than for patients who did not experience any significant network-related delay (15.1% vs. 2.5%).
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A system-related delay has been proved to be linked with long-term mortality. Terkelsen et al. in a follow-up study on 6,209 patients, suggested that a system delay was independently associated with mortality, as were protocol initiation time, transport time and door-to-balloon delay.
A system-related delay of fewer than sixty minutes corresponded to a long-term mortality rate of 15.4% compared to a rate of 30.8% when the delay was 181 to 360 minutes. 20, 21 In agreement with the observations of De Luca et al.,
the present study confirmed that total myocardial ischemic time is the most relevant time interval influencing in-hospital mortality in STEMI. 18 Total ischemic time has a greater impact than PT, PIT, transport time or DTB. Despite the differences recorded in all these components, the in-hospital mortality did not show any significant differences between the groups, as the total ischemic time was approximately the same in all groups. The results also emphasise the importance in reducing the true ischemic time by decreasing the whole system delay and its components, instead of focusing only on the door-to-balloon delay, as a performance measure for triaging patients for primary percutaneous coronary intervention.
CONCLuSIONS
A well-organized STEMI network can shorten protocol initiation and DTB times, thus reaching similar ischemic times and presenting similar mortality rates with the centers located closer to the pPCI center. Early activation of the STEMI protocol could lead to superior results even in areas situated at longer distances from a pPCI center.
